Guardian Pharmacy Services Net Income
| GRDN Stock | 34.01 0.08 0.23% |
As of the 10th of February, Guardian Pharmacy retains the risk adjusted performance of 0.0991, and Market Risk Adjusted Performance of 0.2111. Guardian Pharmacy technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Guardian Pharmacy Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.5421 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -63.9 M | -60.7 M | |
| Net Loss | -63.9 M | -60.7 M | |
| Net Loss | (1.62) | (1.54) | |
| Net Income Per E B T | 1.18 | 0.60 |
Guardian | Net Income | Build AI portfolio with Guardian Stock |
Evaluating Guardian Pharmacy's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Guardian Pharmacy Services's fundamental strength.
Latest Guardian Pharmacy's Net Income Growth Pattern
Below is the plot of the Net Income of Guardian Pharmacy Services over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Guardian Pharmacy financial statement analysis. It represents the amount of money remaining after all of Guardian Pharmacy Services operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Guardian Pharmacy's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Guardian Pharmacy's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (71.03 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Guardian Net Income Regression Statistics
| Arithmetic Mean | 526,548 | |
| Coefficient Of Variation | 7,395 | |
| Mean Deviation | 28,477,098 | |
| Median | 14,678,000 | |
| Standard Deviation | 38,936,702 | |
| Sample Variance | 1516.1T | |
| Range | 122.7M | |
| R-Value | (0.58) | |
| Mean Square Error | 1071.5T | |
| R-Squared | 0.34 | |
| Significance | 0.01 | |
| Slope | (4,478,711) | |
| Total Sum of Squares | 24257.1T |
Guardian Net Income History
Other Fundumenentals of Guardian Pharmacy
Guardian Pharmacy Net Income component correlations
Guardian Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Guardian Pharmacy is extremely important. It helps to project a fair market value of Guardian Stock properly, considering its historical fundamentals such as Net Income. Since Guardian Pharmacy's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Guardian Pharmacy's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Guardian Pharmacy's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Guardian Pharmacy 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Guardian Pharmacy's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Guardian Pharmacy.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Guardian Pharmacy on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Guardian Pharmacy Services or generate 0.0% return on investment in Guardian Pharmacy over 90 days. Guardian Pharmacy is related to or competes with 10X Genomics, Procept Biorobotics, Twist Bioscience, Nuvation Bio, National HealthCare, Quidel, and Mednax. Guardian Pharmacy is entity of United States More
Guardian Pharmacy Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Guardian Pharmacy's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Guardian Pharmacy Services upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.54 | |||
| Information Ratio | 0.0782 | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 4.77 |
Guardian Pharmacy Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardian Pharmacy's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Guardian Pharmacy's standard deviation. In reality, there are many statistical measures that can use Guardian Pharmacy historical prices to predict the future Guardian Pharmacy's volatility.| Risk Adjusted Performance | 0.0991 | |||
| Jensen Alpha | 0.1669 | |||
| Total Risk Alpha | 0.0027 | |||
| Sortino Ratio | 0.0823 | |||
| Treynor Ratio | 0.2011 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Guardian Pharmacy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Guardian Pharmacy February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0991 | |||
| Market Risk Adjusted Performance | 0.2111 | |||
| Mean Deviation | 2.03 | |||
| Semi Deviation | 2.4 | |||
| Downside Deviation | 2.54 | |||
| Coefficient Of Variation | 870.46 | |||
| Standard Deviation | 2.68 | |||
| Variance | 7.17 | |||
| Information Ratio | 0.0782 | |||
| Jensen Alpha | 0.1669 | |||
| Total Risk Alpha | 0.0027 | |||
| Sortino Ratio | 0.0823 | |||
| Treynor Ratio | 0.2011 | |||
| Maximum Drawdown | 13.96 | |||
| Value At Risk | (3.61) | |||
| Potential Upside | 4.77 | |||
| Downside Variance | 6.46 | |||
| Semi Variance | 5.74 | |||
| Expected Short fall | (2.28) | |||
| Skewness | (0.11) | |||
| Kurtosis | 0.9689 |
Guardian Pharmacy Backtested Returns
As of now, Guardian Stock is very steady. Guardian Pharmacy holds Efficiency (Sharpe) Ratio of 0.0613, which attests that the entity had a 0.0613 % return per unit of standard deviation over the last 3 months. We have found twenty-six technical indicators for Guardian Pharmacy, which you can use to evaluate the volatility of the firm. Please check out Guardian Pharmacy's market risk adjusted performance of 0.2111, and Risk Adjusted Performance of 0.0991 to validate if the risk estimate we provide is consistent with the expected return of 0.16%. Guardian Pharmacy has a performance score of 4 on a scale of 0 to 100. The company retains a Market Volatility (i.e., Beta) of 1.48, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Guardian Pharmacy will likely underperform. Guardian Pharmacy right now retains a risk of 2.69%. Please check out Guardian Pharmacy treynor ratio, and the relationship between the coefficient of variation and semi variance , to decide if Guardian Pharmacy will be following its current trending patterns.
Auto-correlation | 0.46 |
Average predictability
Guardian Pharmacy Services has average predictability. Overlapping area represents the amount of predictability between Guardian Pharmacy time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Guardian Pharmacy price movement. The serial correlation of 0.46 indicates that about 46.0% of current Guardian Pharmacy price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.31 | |
| Residual Average | 0.0 | |
| Price Variance | 2.3 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Guardian Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Guardian Pharmacy Services reported net income of (71.03 Million). This is 120.81% lower than that of the Consumer Staples Distribution & Retail sector and significantly lower than that of the Consumer Staples industry. The net income for all United States stocks is 112.44% higher than that of the company.
Guardian Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Guardian Pharmacy's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Guardian Pharmacy could also be used in its relative valuation, which is a method of valuing Guardian Pharmacy by comparing valuation metrics of similar companies.Guardian Pharmacy is currently under evaluation in net income category among its peers.
Guardian Pharmacy ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Guardian Pharmacy's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Guardian Pharmacy's managers, analysts, and investors.Environmental | Governance | Social |
Guardian Fundamentals
| Return On Equity | 0.24 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.03 % | ||||
| Operating Margin | 0.04 % | ||||
| Current Valuation | 2.14 B | ||||
| Shares Outstanding | 36.25 M | ||||
| Shares Owned By Insiders | 37.91 % | ||||
| Shares Owned By Institutions | 59.65 % | ||||
| Number Of Shares Shorted | 1.54 M | ||||
| Price To Book | 11.67 X | ||||
| Price To Sales | 1.54 X | ||||
| Revenue | 1.23 B | ||||
| Gross Profit | 274.32 M | ||||
| EBITDA | (43.43 M) | ||||
| Net Income | (71.03 M) | ||||
| Total Debt | 37.33 M | ||||
| Book Value Per Share | 2.90 X | ||||
| Cash Flow From Operations | 57.96 M | ||||
| Short Ratio | 5.36 X | ||||
| Earnings Per Share | 0.68 X | ||||
| Target Price | 35.0 | ||||
| Number Of Employees | 3.4 K | ||||
| Market Capitalization | 2.15 B | ||||
| Total Asset | 320.81 M | ||||
| Retained Earnings | 17.12 M | ||||
| Working Capital | 7.86 M | ||||
| Net Asset | 320.81 M |
About Guardian Pharmacy Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Guardian Pharmacy Services's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Guardian Pharmacy using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Guardian Pharmacy Services based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Guardian Pharmacy
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Guardian Pharmacy position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Guardian Pharmacy will appreciate offsetting losses from the drop in the long position's value.Moving against Guardian Stock
| 0.58 | HCWC | Healthy Choice Wellness | PairCorr |
| 0.53 | SFM | Sprouts Farmers Market | PairCorr |
| 0.47 | 3GX | HF FOODS GRP | PairCorr |
| 0.47 | HFFG | Hf Foods Group | PairCorr |
| 0.41 | MSS | Maison Solutions | PairCorr |
The ability to find closely correlated positions to Guardian Pharmacy could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Guardian Pharmacy when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Guardian Pharmacy - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Guardian Pharmacy Services to buy it.
The correlation of Guardian Pharmacy is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Guardian Pharmacy moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Guardian Pharmacy moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Guardian Pharmacy can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Will Consumer Staples Distribution & Retail sector continue expanding? Could Guardian diversify its offerings? Factors like these will boost the valuation of Guardian Pharmacy. Market participants price Guardian higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Guardian Pharmacy data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share 0.68 | Revenue Per Share | Quarterly Revenue Growth 0.2 | Return On Assets | Return On Equity |
Understanding Guardian Pharmacy requires distinguishing between market price and book value, where the latter reflects Guardian's accounting equity. The concept of intrinsic value - what Guardian Pharmacy's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Guardian Pharmacy's price substantially above or below its fundamental value.
Please note, there is a significant difference between Guardian Pharmacy's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardian Pharmacy is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Guardian Pharmacy's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.